Chemotherapy Effectiveness in Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer after Third-Line or Later Treatment: An Overtreatment Concern in Everyday Clinical Practice
Lokman Hekim Health Sciences · 2026 · 458-465
DOI: 10.14744/lhhs.2026.02303 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lokman Hekim Health Sciences, 2026. Verfasst von Mustafa Ersoy.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ersoy, M. (2026). Chemotherapy Effectiveness in Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer after Third-Line or Later Treatment: An Overtreatment Concern in Everyday Clinical Practice. Lokman Hekim Health Sciences, 458-465. https://doi.org/10.14744/lhhs.2026.02303
Vancouver
Ersoy M. Chemotherapy Effectiveness in Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer after Third-Line or Later Treatment: An Overtreatment Concern in Everyday Clinical Practice. Lokman Hekim Health Sciences. 2026:458-465. doi:10.14744/lhhs.2026.02303
BibTeX
@article{Ersoy2026,
author = {Ersoy, Mustafa},
title = {Chemotherapy Effectiveness in Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer after Third-Line or Later Treatment: An Overtreatment Concern in Everyday Clinical Practice},
journal = {Lokman Hekim Health Sciences},
year = {2026},
pages = {458--465},
doi = {10.14744/lhhs.2026.02303}
}
EUVIMED